Synergy Pharmaceuticals Inc. (SGYP) said Tuesday that it is offering to sell an aggregate value of $90 million of its common stock in an underwritten public offering, or an aggregate value of $103.5 million of its common stock if the underwriters of such offering exercise their over-allotment option in full.
Credit Suisse, Citigroup and Canaccord Genuity are acting as book-running managers in this offering.
For comments and feedback: editorial@rttnews.com